Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POSNOC - POsitive Sentinel NOde: Adjuvant Therapy Alone Versus Adjuvant Therapy Plus Clearance or Axillary Radiotherapy. A Randomised Controlled Trial of Axillary Treatment in Women With Early Stage Breast Cancer Who Have Metastases in One or Two Sentinel Nodes

NCT02401685 is registered in ClinicalTrials.gov with University Hospitals of Derby and Burton NHS Foundation Trust as lead sponsor.

NCT NCT02401685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POSNOC - POsitive Sentinel NOde: Adjuvant Therapy Alone Versus Adjuvant Therapy Plus Clearance or Axillary Radiotherapy. A Randomised Controlled Trial of Axillary Treatment in Women With Early Stage Breast Cancer Who Have Metastases in One or Two Sentinel Nodes
Lead sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2014
Completion date
December 31, 2026
Enrollment
1,900 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer